Lilly Asia Ventures
Lilly Asia Ventures, based in Asia, backs life sciences and healthtech startups from Pre-Seed to Series B, investing in specialists like Insilico Medicine and Innovent Biologics.
Entry stagePre-seed, Seed, Series A, Series B
Check sizen/a
Leads roundsn/a
FocusLife sciences, Healthtech
Latest fundn/a
Activity0since Sep 2026
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Before you pitch
How to reach them[email protected]
Notable investments
Legend BiotechInnovent BiologicsInsilico MedicineCullinan TherapeuticsGracell BiotechnologiesNextCureRemeGen
In their words
LAVLAV is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.www.lavfund.com
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Lilly Asia Ventures is active
One email when this firm shows new activity. Nothing else.
Firms like Lilly Asia Ventures
On these lists
Questions
What stage does Lilly Asia Ventures invest in?
Lilly Asia Ventures reports entry at pre-seed, seed, series a, series b.
How much does Lilly Asia Ventures invest?
Lilly Asia Ventures has not reported a check size.
Does Lilly Asia Ventures lead rounds?
Lilly Asia Ventures has not reported a lead preference.
Is Lilly Asia Ventures active right now?
No recent activity since September 2026.
Work at Lilly Asia Ventures? Claim or correct this profile.